Corcept Therapeutics vs HealthEquity

Corcept Therapeutics (CORT), health care, and HealthEquity (HQY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

HealthEquity is worth $8.4B on the stock market and Corcept Therapeutics $7.7B: HealthEquity is valued at 10% more. Corcept Therapeutics trades at 52.7 times earnings and HealthEquity at 37.7; operating margins in their latest fiscal years were 5.88% and 24.6%. Over the past year Corcept Therapeutics's share price has moved -7.84% and HealthEquity's +1.79%.

Key facts

Corcept Therapeutics market value
$7.7B
HealthEquity market value
$8.4B
Corcept Therapeutics P/E
52.7
HealthEquity P/E
37.7
Corcept Therapeutics revenue
$761.4MFY to 2025-12-31
HealthEquity revenue
$1.3BFY to 2026-01-31
Superinvestors holding both
0

Market values as of .

Corcept Therapeutics vs HealthEquity: every measure side by side
Measure Corcept Therapeutics HealthEquity
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312026-01-31
Size
Market cap$7.7Blower$8.4Bhigher
Revenue$761.4Mlower$1.3Bhigher
Earnings$99.7Mlower$215.2Mhigher
Employees730lower2,814higher
Total assets$836.7Mlower$3.4Bhigher
Valuation
P/E52.7higher37.7lower
P/S10.1higher6.4lower
P/B9.2higher4.2lower
Dividend yield0.00%0.00%
Profitability
Operating margin5.88%lower24.6%higher
Balance sheet
Net assets$647.8Mlower$2.1Bhigher
Total liabilities$188.8Mlower$1.3Bhigher
Total debt—$957.4M
Cash on hand$120.5Mlower$318.9Mhigher
Price change
Today+1.23%higher-2.62%lower
1 year-7.84%lower+1.79%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Corcept Therapeutics only (1)

HealthEquity only (1)

Percentages are each holding's share of that investor's reported portfolio. Who owns CORT · Who owns HQY

Further comparisons

Learn

Questions and answers

Which is bigger, Corcept Therapeutics or HealthEquity?

By market value, HealthEquity is the larger: $8.4B against $7.7B for Corcept Therapeutics. By revenue in its latest fiscal year, HealthEquity is the larger: $1.3B against $761.4M for Corcept Therapeutics.

Which has the higher P/E ratio?

Corcept Therapeutics: 52.7, against 37.7 for HealthEquity. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

HealthEquity: 24.6%, against 5.88% for Corcept Therapeutics. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Corcept Therapeutics and HealthEquity?

None of the tracked superinvestors holds both in their latest 13F filing. 1 holds Corcept Therapeutics and 1 holds HealthEquity.

Cite this page

Funkfolio, “Corcept Therapeutics vs HealthEquity”, data as of 18 November 2026. https://funkfolio.com/compare/cort-vs-hqy

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.